Skip to content
Zarella Official
Training

Who should not take Paraxanthine

A
Andriy Melnyk · 9 min read
Who should not take Paraxanthine

Paraxanthine is a stimulant, not a neutral vitamin. The editorial team gathered the situations in which taking this substance is contraindicated or requires prior consultation with a doctor, and explained why the risk is higher in these groups.

General principles

Paraxanthine is sold as a dietary supplement, and many people take this as a guarantee of safety for everyone. In fact it is a methylxanthine-class stimulant that affects the nervous and cardiovascular systems. So the list of people who should not take it, or may take it only after consulting a doctor, is quite broad.

There are essentially no specific clinical studies of paraxanthine in risk groups. The participants of the available work were healthy adults. So we define the contraindications by relying on the pharmacology of the substance and on the well-studied risks of caffeine, from which paraxanthine is formed in the body.

Let us distinguish two levels of restrictions. Absolute — situations in which taking a concentrated stimulant in supplement form is not justified at all. Relative — conditions in which the decision should be made by a doctor, weighing the benefits and risks.

It is also important to remember that the absence of safety data in a particular group does not mean the substance is safe for it. That is why, for pregnant women, adolescents and people with serious chronic illnesses, the editorial team advises refraining from experiments.

Pregnancy, breastfeeding, children

During pregnancy the metabolism of caffeine slows substantially, especially in the third trimester, and methylxanthines cross the placenta. The American College of Obstetricians and Gynecologists (ACOG) recommends limiting caffeine intake to about 200 mg per day; EFSA adheres to the same limit for pregnant and breastfeeding women.

Paraxanthine in supplement form is an additional concentrated methylxanthine on top of ordinary coffee or tea. There are no studies of its safety during pregnancy, so the editorial team considers taking it during this period unjustified.

During breastfeeding, methylxanthines pass into breast milk. Newborns metabolize caffeine very slowly, so they can accumulate it and react with restlessness and sleep disturbance. It is logical to expect the same for paraxanthine.

Children and adolescents are another group for whom concentrated stimulants are not intended. Their nervous and cardiovascular systems are more sensitive and their body weight is lower, so the risk of exceeding a safe amount is higher. A systematic review by Wikoff and colleagues specifically emphasizes the lower permissible amount of caffeine for this age group.

Do not take pregnancy, breastfeeding children and adolescents severe arrhythmias Only after consulting a doctor hypertension, heart disease anxiety disorders, insomnia epilepsy, hyperthyroidism Taking medications CYP1A2 inhibitors, stimulants, lithium preparations, MAO inhibitors
Fig. 1. Schematically: the main groups of restrictions for taking paraxanthine (an editorial generalization based on the pharmacology of methylxanthines).
Кому не можна приймати Параксантин — ілюстрація
Photo:Hannah Coleman/Unsplash

The heart, blood vessels and the thyroid gland

Cardiovascular diseases are the most important group of relative, and in severe cases absolute, contraindications. A study by Benowitz and colleagues showed that paraxanthine raises blood pressure and the level of adrenaline in the blood, that is, it loads the heart similarly to caffeine.

People with uncontrolled arterial hypertension, cardiac arrhythmias (in particular with episodes of tachycardia or extrasystoles), coronary heart disease, or after a heart attack or stroke, must not take stimulants without a cardiologist's permission. Even if ordinary coffee is well tolerated, a concentrated dose before intense training is a different situation.

Separately, it is worth mentioning people with undiagnosed heart problems. Fainting during exertion, sudden shortness of breath, chest pain, cases of sudden death in young relatives — all are grounds for examination before any experiments with stimulants.

Hyperthyroidism also increases sensitivity to stimulants: an excess of thyroid hormones already accelerates the heartbeat and metabolism, and methylxanthines can intensify these manifestations.

The nervous system, stomach and liver

Anxiety and panic disorders are another significant restriction. Although animal studies suggest that paraxanthine is less anxiogenic than caffeine, in humans this has not been proven. Methylxanthines can provoke panic attacks in susceptible individuals.

Chronic insomnia, on the contrary, is a situation where any stimulant can worsen the underlying problem. Blockade of adenosine receptors delays falling asleep, and sleep deprivation in itself reduces athletic performance and recovery.

Epilepsy requires caution: methylxanthines, in particular theophylline, are known for their ability under certain conditions to lower the seizure threshold. There are no separate data for paraxanthine, so the decision should be made by a neurologist.

Stomach diseases — gastroesophageal reflux disease, peptic ulcer disease, gastritis — can be aggravated by stimulation of acid secretion. Severe liver diseases slow the metabolism of methylxanthines, which leads to accumulation of the substance in the blood and intensification of side effects.

Drug groupExamplesPossible consequence
CYP1A2 inhibitorsFluvoxamine, ciprofloxacinSlowing of methylxanthine elimination, intensification of the effect
CNS stimulantsDrugs for treating ADHDSummation of stimulation, tachycardia
MAO inhibitorsSome antidepressantsRisk of increased blood pressure
Lithium preparationsLithium carbonateMethylxanthines affect the elimination of lithium
TheophyllineBronchodilatorsSummation of methylxanthine effects

Medications and warning symptoms

Drug interactions are an often underestimated cause of problems. Paraxanthine is further metabolized with the involvement of liver enzymes, primarily CYP1A2. Drugs that inhibit this enzyme can raise the concentration of methylxanthines in the blood several-fold, as is described in detail for caffeine in the review by Nehlig.

People taking antidepressants, drugs for treating attention deficit hyperactivity disorder, bronchodilators, antiarrhythmic drugs or drugs for high blood pressure should discuss paraxanthine with a doctor. The same applies to oral contraceptives, which slow the metabolism of caffeine.

For athletes it is important to know that paraxanthine is not included in the WADA Prohibited List, and caffeine is in the monitoring program. However, the composition of complex products must be checked, since undeclared prohibited stimulants are sometimes found in pre-workout blends.

Here are the signs at which intake should be stopped immediately and a doctor consulted:

  • a strong or irregular heartbeat;
  • chest pain or pressure, shortness of breath;
  • severe headache, dizziness, fainting;
  • marked agitation, tremor, seizures.

These symptoms may indicate a serious reaction that requires medical attention.

Important.This article is for informational purposes only and is not medical advice. If you have a chronic illness, are pregnant, are breastfeeding or are taking medications, be sure to consult a doctor before taking paraxanthine or any stimulant.

Editorial conclusions

Paraxanthine is contraindicated during pregnancy and breastfeeding, for children and adolescents, and for people with severe heart rhythm disturbances.

Hypertension, heart disease, hyperthyroidism, anxiety disorders, insomnia, epilepsy, and diseases of the stomach and liver require a mandatory consultation with a doctor before taking it.

A separate risk zone is drug interactions, especially with drugs that inhibit the CYP1A2 enzyme and with other stimulants.

To get the full picture, also read "Side effects of Paraxanthine", "How to take Paraxanthine: dosage, timing, duration" and "Paraxanthine: what it is and how it works".

References

  1. ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy. Obstet Gynecol. 2010;116(2 Pt 1):467–468.
  2. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the safety of caffeine. EFSA J. 2015;13(5):4102.
  3. Wikoff D, Welsh BT, Henderson R, et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol. 2017;109(Pt 1):585–648.
  4. Benowitz NL, Jacob P 3rd, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther. 1995;58(6):684–691.
  5. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384–411.
  6. Arnaud MJ. Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handb Exp Pharmacol. 2011;(200):33–91.
  7. World Anti-Doping Agency. The 2025 Monitoring Program. Montreal: WADA; 2025.
Share:
A

Andriy Melnyk

A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.

Related articles